Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...

RSV is "a common respiratory virus that infects the nose, throat, and lungs. RSV symptoms make it difficult to distinguish it ...

Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you know for sure? Here are the ...

Respiratory viruses typically experience their highest levels in the wintertime, and this year will likely be no different.

The study followed 38 immunocompromised adults, aged 64 to 72, who received either the Arexvy or Abrysvo RSV vaccine. Researchers found that people aged 60 and older who are immunocompromised ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity -; primarily organ transplant recipients who take immunosuppressive medications to reduce the risk of ...

The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...

Respiratory syncytial virus (RSV) infections can lead to serious complications, particularly in infants and older adults aged ...

RSVpreF vaccination is effective against RSV-related lower respiratory tract disease among adults aged 60 years or older.

More Americans believe in the effectiveness of vaccines developed to protect newborns and seniors against respiratory ...

The Communicable Disease Control Department (CDC) warns of a human metapneumovirus (hMPV) outbreak in China. hMPV causes ...